Delivery Order SPE2DB22D2108-SPE2DB24FU3EN

Award Date 2/6/24
Potential Completion Date 2/7/24
Potential Value $36K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a $3,498.29 firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication HUMIRA(CF) PEN 40 MG/0.4 MLS. This delivery order is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally....
The U.S. Defense Logistics Agency (DLA) awarded a $1,174.44 firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira(CF) Pen 40 mg/0.4 mls. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
The Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order worth $14,819.92 to Amerisourcebergen Drug Corp for the supply of Humira (CF) Pen 40 mg/0.4 mL medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical division, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
The Defense Logistics Agency (DLA) awarded a $8,821.76 firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide HUMIRA(CF) PEN 40 MG/0.4 MLS medication. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
The Defense Logistics Agency (DLA) awarded a $3,645.00 firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (CF) Pen 40 mg/0.4 mls. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, which runs through November 2026, enables DLA to efficiently procure a comprehensive range of...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply the DLA with HUMIRA(CF) PEN 40 MG/0.4 MLS. This order, valued at $75,138.37, has an ultimate completion date of April 22, 2024. Amerisourcebergen also holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025, to provide a comprehensive range of pharmaceutical products and medical...
The U.S. Defense Logistics Agency (DLA) awarded a $5,541.48 Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp, Corporate Office Division, to provide HUMIRA PEN 40 MG/0.8 MLS pharmaceutical products. This single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical...
The U.S. Defense Logistics Agency (DLA) awarded a $43,798.19 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (CF) Pen 40 mg/0.4 mL medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military...
The Defense Logistics Agency (DLA) awarded a $12,824.64 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, with a period of performance through August 26, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by the DLA and other agencies to provide a wide range of medical commodities, including prescription...
The U.S. Defense Logistics Agency (DLA) awarded a $11,082.96 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty pharmaceutical product. This delivery order was placed under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999 through December 2025 for a broad range of medical commodities to support military treatment programs...
  • SPE2DB22D2108
    Indefinite Delivery Contract
  • SPE2DB22D2108-SPE2DB24FU3EN
    Delivery Order

The Defense Logistics Agency (DLA) awarded a $36,012.49 firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Humira(CF) Pen 40 mg/0.4 mL medical supplies. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical to supply a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. AmerisourceBergen also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 5/14/25, 10:38 AM